Detalles de la búsqueda
1.
Comparative Analysis of Morphological and Functional Effects of 225Ac- and 177Lu-PSMA Radioligand Therapies (RLTs) on Salivary Glands.
Int J Mol Sci
; 24(23)2023 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38069166
2.
Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer.
BMC Cancer
; 19(1): 696, 2019 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31307411
3.
Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer.
Br J Cancer
; 119(7): 1-9, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30287916
4.
Treatment of carcinoma in situ of the urinary bladder with an alpha-emitter immunoconjugate targeting the epidermal growth factor receptor: a pilot study.
Eur J Nucl Med Mol Imaging
; 45(8): 1364-1371, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29644393
5.
Dual-Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy.
Chemistry
; 24(3): 547-550, 2018 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28833667
6.
Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis.
Eur J Nucl Med Mol Imaging
; 39(4): 602-12, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22237842
7.
Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest.
Eur J Nucl Med Mol Imaging
; 39(12): 1886-97, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22872310
8.
177Lu-immunotherapy of experimental peritoneal carcinomatosis shows comparable effectiveness to 213Bi-immunotherapy, but causes toxicity not observed with 213Bi.
Eur J Nucl Med Mol Imaging
; 38(2): 312-22, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21072513
9.
Differentiation of acute myeloid leukemia (AML) cells with ATRA reduces 18F-FDG uptake and increases sensitivity towards ABT-737-induced apoptosis.
Leuk Lymphoma
; 62(3): 630-639, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33140666
10.
Diverse metabolic response of cancer cells treated with a 213Bi-anti-EGFR-immunoconjugate.
Sci Rep
; 11(1): 6227, 2021 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33737524
11.
Drug Repurposing of Pantoprazole and Vitamin C Targeting Tumor Microenvironment Conditions Improves Anticancer Effect in Metastatic Castration-Resistant Prostate Cancer.
Front Oncol
; 11: 660320, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34307134
12.
Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression.
J Nucl Med
; 62(9): 1228-1234, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33517324
13.
Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA.
Eur Urol
; 79(3): 343-350, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33293081
14.
Differential gene expression triggered by highly cytotoxic alpha-emitter-immunoconjugates in gastric cancer cells.
Invest New Drugs
; 28(1): 49-60, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19139817
15.
Targets for Therapy of Bladder Cancer.
Semin Nucl Med
; 50(2): 162-170, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32172801
16.
Increased Tumoral Microenvironmental pH Improves Cytotoxic Effect of Pharmacologic Ascorbic Acid in Castration-Resistant Prostate Cancer Cells.
Front Pharmacol
; 11: 570939, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33071784
17.
Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment.
Eur J Nucl Med Mol Imaging
; 36(9): 1434-42, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19352653
18.
Assessment of 213Bi-anti-EGFR MAb treatment efficacy in malignant cancer cells with [1-13C]pyruvate and [18F]FDG.
Sci Rep
; 9(1): 8294, 2019 06 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31165773
19.
Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients.
PLoS One
; 14(2): e0212968, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30811511
20.
Development and evaluation of peptidic ligands targeting tumour-associated urokinase plasminogen activator receptor (uPAR) for use in alpha-emitter therapy for disseminated ovarian cancer.
Eur J Nucl Med Mol Imaging
; 35(1): 53-64, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17891393